Malaria Chemoprotection Malaria
malaria parasites
risk of malaria
Drug Repurposing
Parasite Resistance
set of likely drug candidates
profiling
parasite growth
Effects
likely candidates
known anti-diabetic drug
Limited Number of Drugs effective
Limited Use
toxicity studies
IP Strategy
IP protection
PoC funding
pre-clinical studies
draft early stage Regulatory Approval Roadmap
conduct Market Analysis
serious parasitic disease
current chemoprotective treatments
restrictions
vaccine
reduced propensity
fewer
genetic traits
preliminary data
novel mechanism of action
ERC-funded research
people
shortcomings
therapeutic dose
Business Case
pregnancy
efficacy
worldâ€™s population
cure
estimated death toll
fact
following aims
prevention
users